Načítá se...
PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D
Activating mutations in PIK3CA, the gene encoding phosphoinositide-(3)-kinase α (PI3Kα), are frequently found in estrogen receptor (ER)–positive breast cancer. PI3Kα inhibitors, now in late-stage clinical development, elicit a robust compensatory increase in ER-dependent transcription that limits th...
Uloženo v:
| Vydáno v: | Science |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5485411/ https://ncbi.nlm.nih.gov/pubmed/28336670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aah6893 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|